Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nutraceutical/Supreme Court update

This article was originally published in The Tan Sheet

Executive Summary

Solicitor General Paul D. Clement has asked the clerk of the Supreme Court to give his office an extension until March 7 to file the government's response to Nutraceutical Corp.'s petition for writ of certiorari, Nutraceutical attorney Jonathan Emord tells "The Tan Sheet" in a Feb. 1 e-mail. "This is significant. Of approximately 10,000 cert petitions filed within the Court, the Solicitor General's office responds to but a fraction of these," Emord writes. The Department of Justice "uses criteria for assessing cert worthiness and files responses only to those petitions that they think may be granted by the Court," he explains. Nutraceutical filed its petition for writ of certiorari Jan. 3 (1"The Tan Sheet" Jan. 8, 2007, p. 8). Separately, Nutraceutical filed a pleading Feb. 9 in the U.S. District Court for the District of Utah. The pleading rebuts FDA's Jan. 18 response to Nutraceutical's renewal of its case against the agency (2"The Tan Sheet" Jan. 29, 2007, p. 9)...

You may also be interested in...

FDA Defends Ephedra Ban Procedures In Nutraceutical Case Filing

FDA followed required rulemaking procedures in issuing a final rule that banned ephedra dietary supplements, the agency argues in a response brief filed in its ongoing legal battle with Nutraceutical Corp

Will Nutraceutical Succeed In Asking Supreme Court To Review Ephedra Ban?

According to food and drug lawyer Marc Ullman, it is unlikely the Supreme Court will review the 10th Circuit Court of Appeals decision affirming FDA's ban of ephedra in dietary supplements

CEOs Face Grilling On Vaccine Supply In EU

AstraZeneca's CEO and other leaders from COVID-19 vaccine companies will face some tough questions in Brussels, but the European Commission wants to put differences behind it and solve the vaccine supply problem as soon as possible.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts